Education
About Us
Working with TipRanks
Follow Us
Medical Data Vision Co.Ltd. (JP:3902)
:3902
3902 Stock Chart & Stats
¥1688.00
¥12.00(2.93%)
At close: 4:00 PM EST
¥1688.00
¥12.00(2.93%)
Day’s Range― - ―
52-Week Range¥332.00 - ¥1,693.00
Previous CloseN/A
Volume230.80K
Average Volume (3M)221.94K
Market Cap
¥65.51B
Enterprise Value¥61.89B
Total Cash (Recent Filing)¥1.83B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)227.9
Beta0.09
Next Earnings
May 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.39%
Share Statistics
EPS (TTM)5.94
Shares Outstanding40,027,527
10 Day Avg. Volume317,960
30 Day Avg. Volume221,940
Financial Highlights & Ratios
PEG Ratio-1.68
Price to Book (P/B)20.73
Price to Sales (P/S)9.77
P/FCF Ratio88.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
No Debt; Conservatively Positioned Balance SheetZero reported debt materially reduces financial risk and gives the company flexibility to fund product development, M&A or weather downturns without refinancing pressure. This durable capital structure supports multi‑year strategy execution and resilience to earnings volatility.
Recurring Data‑platform And Services Business ModelA subscription/usage and services mix tied to healthcare data platforms creates recurring, sticky revenue from pharma and life‑science customers. Structural secular demand for healthcare data and analytics supports predictable revenue streams and longer customer lifecycles.
Very High Gross MarginsSustained gross margins near software‑like levels indicate scalable unit economics: incremental revenue largely flows to the bottom line once fixed platform costs are covered. This provides a durable opportunity to expand operating profitability as top line stabilizes.
Bears Say
Operating Profitability Collapsed In 2024A sharp collapse in operating profitability followed by only partial recovery signals structural sensitivity of margins to cost allocation, project timing or pricing pressure. Persistent thin operating margins reduce ability to self‑fund growth and amplify earnings risk.
Inconsistent Cash Generation Across YearsLarge swings in operating and free cash flow indicate exposure to working‑capital swings or one‑off items, complicating capital planning. Even with recent rebound, inconsistent cash conversion reduces predictability for investments, dividends or buybacks over the next several quarters.
Choppy Revenue Growth TrajectoryErratic revenue momentum undermines visibility for scaling the business and achieving operating leverage. Reliance on project timing, client concentration or uneven platform adoption can delay margin recovery and makes multi‑quarter forecasting less reliable.
Medical Data Vision Co.Ltd. News
3902 FAQ
What was Medical Data Vision Co.Ltd.’s price range in the past 12 months?
Medical Data Vision Co.Ltd. lowest stock price was ¥332.00 and its highest was ¥1693.00 in the past 12 months.
What is Medical Data Vision Co.Ltd.’s market cap?
Medical Data Vision Co.Ltd.’s market cap is ¥65.51B.
When is Medical Data Vision Co.Ltd.’s upcoming earnings report date?
Medical Data Vision Co.Ltd.’s upcoming earnings report date is May 07, 2026 which is in 79 days.
How were Medical Data Vision Co.Ltd.’s earnings last quarter?
Medical Data Vision Co.Ltd. released its earnings results on Feb 09, 2026. The company reported ¥5.94 earnings per share for the quarter, beating the consensus estimate of N/A by ¥5.94.
Is Medical Data Vision Co.Ltd. overvalued?
According to Wall Street analysts Medical Data Vision Co.Ltd.’s price is currently Overvalued.
Does Medical Data Vision Co.Ltd. pay dividends?
Medical Data Vision Co.Ltd. pays a Annually dividend of ¥9 which represents an annual dividend yield of 0.39%. See more information on Medical Data Vision Co.Ltd. dividends here
What is Medical Data Vision Co.Ltd.’s EPS estimate?
Medical Data Vision Co.Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medical Data Vision Co.Ltd. have?
Medical Data Vision Co.Ltd. has 40,027,527 shares outstanding.
What happened to Medical Data Vision Co.Ltd.’s price movement after its last earnings report?
Medical Data Vision Co.Ltd. reported an EPS of ¥5.94 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.059%.
Which hedge fund is a major shareholder of Medical Data Vision Co.Ltd.?
Currently, no hedge funds are holding shares in JP:3902
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Medical Data Vision Co.Ltd.
Medical Data Vision Co., Ltd. develops, produces, maintains, and sells medical information integration systems in Japan. The company also offers medical data analysis, survey, and consulting services; management consulting services for medical institutions; and medical data services, as well as plans, designs, develops, and operates portal sites. It provides its services to pharmaceutical companies, medical device manufacturer, academia, research institution, and health insurance providers. The company was founded in 2003 and is headquartered in Tokyo, Japan.
Technical Analysis
Options Prices
Currently, No data available
---